|Report ID : RC-50526||Category : Chemical And Materials|
|Published Date : Oct-19||Pages : 121||Format : PDF|
The global Valine market was valued at $XX million in 2018, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Valine from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Valine market. Leading players of Valine including: Ajinomoto Kyowa Hakko Evonik CJ Fufeng Group Maidan Biology Meihua Group Sanxia Pharmaceutical Tianjin Tianan Wellman Bioscience Jinghai Amino Acid Bafeng Pharmaceutical Jiahe Biotech Luzhou Group Jirong Pharmaceutical Market split by Type, can be divided into: L-Valine D-Valine Others Market split by Application, can be divided into: Feed Food Medicine Other Market split by Sales Channel, can be divided into: Direct Channel Distribution Channel Market segment by Region/Country including: North America (United States, Canada and Mexico) Europe (Germany, UK, France, Italy, Russia and Spain etc.) Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.) South America Brazil, Argentina, Colombia and Chile etc.) Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.) If you have any special requirement, please let us know and we can provide you the report as your requirement.
Table of Contents Chapter 1 Valine Market Overview 1.1 Valine Definition 1.2 Global Valine Market Size Status and Outlook (2013-2028) 1.3 Global Valine Market Size Comparison by Region (2013-2028) 1.4 Global Valine Market Size Comparison by Type (2013-2028) 1.5 Global Valine Market Size Comparison by Application (2013-2028) 1.6 Global Valine Market Size Comparison by Sales Channel (2013-2028) 1.7 Valine Market Dynamics 1.7.1 Market Drivers/Opportunities 1.7.2 Market Challenges/Risks 1.7.3 Market News (Mergers/Acquisitions/ Expansion) Chapter 2 Valine Market Segment Analysis by Player 2.1 Global Valine Sales and Market Share by Player (2016-2018) 2.2 Global Valine Revenue and Market Share by Player (2016-2018) 2.3 Global Valine Average Price by Player (2016-2018) 2.4 Players Competition Situation & Trends 2.5 Conclusion of Segment by Player Chapter 3 Valine Market Segment Analysis by Type 3.1 Global Valine Market by Type 3.1.1 L-Valine 3.1.2 D-Valine 3.1.3 Others 3.2 Global Valine Sales and Market Share by Type (2013-2018) 3.3 Global Valine Revenue and Market Share by Type (2013-2018) 3.4 Global Valine Average Price by Type (2013-2018) 3.5 Leading Players of Valine by Type in 2018 3.6 Conclusion of Segment by Type Chapter 4 Valine Market Segment Analysis by Application 4.1 Global Valine Market by Application 4.1.1 Feed 4.1.2 Food 4.1.3 Medicine 4.1.4 Other 4.2 Global Valine Sales and Market Share by Application (2013-2018) 4.3 Leading Consumers of Valine by Application in 2018 4.4 Conclusion of Segment by Application Chapter 5 Valine Market Segment Analysis by Sales Channel 5.1 Global Valine Market by Sales Channel 5.1.1 Direct Channel 5.1.2 Distribution Channel 5.2 Global Valine Sales and Market Share by Sales Channel (2013-2018) 5.3 Leading Distributors/Dealers of Valine by Sales Channel in 2018 5.4 Conclusion of Segment by Sales Channel Chapter 6 Valine Market Segment Analysis by Region 6.1 Global Valine Market Size and CAGR by Region (2013-2028) 6.2 Global Valine Sales and Market Share by Region (2013-2018) 6.3 Global Valine Revenue and Market Share by Region (2013-2018) 6.4 North America 6.4.1 North America Market by Country 6.4.2 North America Valine Market Share by Type 6.4.3 North America Valine Market Share by Application 6.4.4 United States 6.4.5 Canada 6.4.6 Mexico 6.5 Europe 6.5.1 Europe Market by Country 6.5.2 Europe Valine Market Share by Type 6.5.3 Europe Valine Market Share by Application 6.5.4 Germany 6.5.5 UK 6.5.6 France 6.5.7 Italy 6.5.8 Russia 6.5.9 Spain 6.6 Asia-Pacific 6.6.1 Asia-Pacific Market by Country 6.6.2 Asia-Pacific Valine Market Share by Type 6.6.3 Asia-Pacific Valine Market Share by Application 6.6.4 China 6.6.5 Japan 6.6.6 Korea 6.6.7 India 6.6.8 Southeast Asia 6.6.9 Australia 6.7 South America 6.7.1 South America Market by Country 6.7.2 South America Valine Market Share by Type 6.7.3 South America Valine Market Share by Application 6.7.4 Brazil 6.7.5 Argentina 6.7.6 Colombia 6.7.7 Chile 6.8 Middle East & Africa 6.8.1 Middle East & Africa Market by Country 6.8.2 Middle East & Africa Valine Market Share by Type 6.8.3 Middle East & Africa Valine Market Share by Application 6.8.4 Egypt 6.8.5 Saudi Arabia 6.8.6 South Africa 6.8.7 Nigeria 6.9 Conclusion of Segment by Region Chapter 7 Profile of Leading Valine Players 7.1 Ajinomoto 7.1.1 Company Snapshot 7.1.2 Product/Business Offered 7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share) 7.1.4 Strategy and SWOT Analysis 7.2 Kyowa Hakko 7.3 Evonik 7.4 CJ 7.5 Fufeng Group 7.6 Maidan Biology 7.7 Meihua Group 7.8 Sanxia Pharmaceutical 7.9 Tianjin Tianan 7.10 Wellman Bioscience 7.11 Jinghai Amino Acid 7.12 Bafeng Pharmaceutical 7.13 Jiahe Biotech 7.14 Luzhou Group 7.15 Jirong Pharmaceutical Chapter 8 Upstream and Downstream Analysis of Valine 8.1 Industrial Chain of Valine 8.2 Upstream of Valine 8.2.1 Raw Materials 8.2.2 Labor Cost 8.2.3 Manufacturing Expenses 8.2.4 Manufacturing Cost Structure 8.2.5 Manufacturing Process 8.3 Downstream of Valine 8.3.1 Leading Distributors/Dealers of Valine 8.3.2 Leading Consumers of Valine Chapter 9 Development Trend of Valine (2019-2028) 9.1 Global Valine Market Size (Sales and Revenue) Forecast (2019-2028) 9.2 Global Valine Market Size and CAGR Forecast by Region (2019-2028) 9.3 Global Valine Market Size and CAGR Forecast by Type (2019-2028) 9.4 Global Valine Market Size and CAGR Forecast by Application (2019-2028) 9.5 Global Valine Market Size Forecast by Sales Channel (2019-2028) Chapter 10 Appendix 10.1 Research Methodology 10.2 Data Sources 10.3 Disclaimer 10.4 Analysts Certification
Akasaka biz tower,
5-3-1 akasaka minato-ku,
13284 bluejacket street overland park,
KS 66213 United States